Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Drugs

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    January 2021
  1. HANZEL J, Ma C, Casteele NV, Khanna R, et al
    Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Drugs. 2021 Jan 5. pii: 10.1007/s40265-020-01460.
    PubMed     Abstract available


    March 2020
  2. VUITTON L, Peyrin-Biroulet L
    Pharmacological Prevention of Postoperative Recurrence in Crohn's Disease.
    Drugs. 2020;80:385-399.
    PubMed     Abstract available


    February 2020
  3. KIM H, Alten R, Avedano L, Dignass A, et al
    The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.
    Drugs. 2020;80:99-113.
    PubMed     Abstract available


    July 2019
  4. MA C, Battat R, Dulai PS, Parker CE, et al
    Innovations in Oral Therapies for Inflammatory Bowel Disease.
    Drugs. 2019 Jul 17. pii: 10.1007/s40265-019-01169.
    PubMed     Abstract available


    June 2019
  5. PICARDO S, Seow CH
    A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy.
    Drugs. 2019 Jun 10. pii: 10.1007/s40265-019-01141.
    PubMed     Abstract available


  6. MCKEAGE K, Duggan S
    Risankizumab: First Global Approval.
    Drugs. 2019;79:893-900.
    PubMed     Abstract available


    March 2018
  7. SCOTT LJ
    Ferric Carboxymaltose: A Review in Iron Deficiency.
    Drugs. 2018;78:479-493.
    PubMed     Abstract available


    January 2018
  8. BERMEJO F, Guerra I, Algaba A, Lopez-Sanroman A, et al
    Pharmacological Approach to the Management of Crohn's Disease Patients with Perianal Disease.
    Drugs. 2018;78:1-18.
    PubMed     Abstract available


    July 2017
  9. LAMB YN, Duggan ST
    Ustekinumab: A Review in Moderate to Severe Crohn's Disease.
    Drugs. 2017;77:1105-1114.
    PubMed     Abstract available


    May 2017
  10. FLAMANT M, Rigaill J, Paul S, Roblin X, et al
    Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future Prospects.
    Drugs. 2017 May 18. doi: 10.1007/s40265-017-0755.
    PubMed     Abstract available


    March 2017
  11. HINDRYCKX P, Novak G, Vande Casteele N, Khanna R, et al
    Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.
    Drugs. 2017 Mar 1. doi: 10.1007/s40265-017-0719.
    PubMed    


    February 2017
  12. HINDRYCKX P, Novak G, Vande Casteele N, Khanna R, et al
    Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.
    Drugs. 2017 Feb 23. doi: 10.1007/s40265-017-0693.
    PubMed     Abstract available


    January 2017
  13. BOAL CARVALHO P, Cotter J
    Mucosal Healing in Ulcerative Colitis: A Comprehensive Review.
    Drugs. 2017 Jan 11. doi: 10.1007/s40265-016-0676.
    PubMed     Abstract available


    September 2016
  14. GECSE KB, Lakatos PL
    Biosimilar Monoclonal Antibodies for Inflammatory Bowel Disease: Current Comfort and Future Prospects.
    Drugs. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: